Advertisement

Topics

Jiangsu Hengrui Medicine Co., Ltd. Company Profile

16:45 EDT 17th August 2018 | BioPortfolio

Jiangsu Hengrui Medicine Co., Ltd., established in 1970, is a leading biopharmaceutical company based in China with annual net sales of over $1.6 billion in 2016. Hengrui is devoted to empowering healthier lives through research, and currently has 3 programs under China NDA as well as 21 new molecular entities in clinical development in China, U.S., and Australia, across oncology, anesthesiology & pain management, immunology & inflammation, and cardiovascular & metabolic diseases.


News Articles [562 Associated News Articles listed on BioPortfolio]

Jiangsu Hengrui Medicine Co Ltd 600276 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15022018] Prices from USD $250

SummaryJiangsu Hengrui Medicine Co Ltd Jiangsu Hengrui is a biopharmaceutical company that focuses on the research, development, manufacture and distribution of innovative pharmaceutical products. Its...

Jiangsu Hengrui Medicine Co Ltd 600276 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25042018] Prices from USD $250

SummaryJiangsu Hengrui Medicine Co Ltd Jiangsu Hengrui is a biopharmaceutical company that focuses on the research, development, manufacture and distribution of innovative pharmaceutical products. Its...

Incyte and Hengrui end PD-1 mAb deal

20152023 World Atorvastatin Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 16012018] Prices from USD $2800

SummaryAtorvastatin is a pharmaceutical raw material in the production of atorvastatin drug trade name: Lipitor, which is a prescription medicine that lowers the LDL cholesterol and triglycerides in t...

Global and North America Atorvastatin Market Status and Future Forecast 20132023 [Report Updated: 09022018] Prices from USD $2500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

BRIEF—Trevena partners with Jiangsu Nhwa to target Chinese opioid market

US-based Trevena and China’s Jiangsu Nhwa Pharmaceutical have agreed a deal to develop and sell Trevena’s…

Gathering Talents and Creating a Dream for the Future - Jiangsu Industrial Technology Research ...

The Third GVRC 2018 will be hosted by Jiangsu Industrial Technology Research Institute (JITRI). As the keynote speaker on the morning of June 27, Read more...

20182023 UK Capecitabine Market Report Status and Outlook [Report Updated: 13032018] Prices from USD $3360

In 2017, the Capecitabine market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In UK market, the top players include Roche Teva ...

PubMed Articles [957 Associated PubMed Articles listed on BioPortfolio]

Population data and phylogenetic structure of Han population from Jiangsu province of China on GlobalFiler STR loci.

Forensic statistical parameters based on allelic frequencies of commonly used short tandem repeats were estimated for the Han population of Jiangsu province from P.R. China. The 6-dye GlobalFiler™ P...

Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, China.

Jiangsu Province, China, is highly developed economically and culturally, and has a high prevalence of lung cancer. We aimed to evaluate the diagnostic procedures, genetic aberration analysis status, ...

The effect of ambient temperature on the activity of influenza and influenza like illness in Jiangsu Province, China.

We aimed to evaluate and quantify the association between ambient temperature and activity of influenza like illness (ILI) and influenza in Jiangsu Province, China.

Identifying the Origins and Spatial Distributions of Heavy Metals in the Soils of the Jiangsu Coast.

A total of 239 samples of surface soils were collected along the Xiangshui to Rudong coast, in Jiangsu Province, and analyzed for Cd, Cr, Cu, Hg, Ni, Pb, and Zn. A multivariate analysis was applied to...

Cases diagnosis of imported malaria in Jiangsu province, 2014-2016.

To understand the situation related to health seeking and diagnosis of imported malaria and to provide practical measures for malaria elimination in Jiangsu province.Data on imported malaria cases in ...

Clinical Trials [1302 Associated Clinical Trials listed on BioPortfolio]

Real-world Daptomycin Use in Chinese ICUs

Analyze the effectiveness and safety of Daptomycin(Jiangsu Hengrui Medicine Co., Ltd) in Gram-positive infections in Chinese Intensive Care Units by using the real-world data platform, htt...

A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure

Hepatocellular carcinoma (HCC) is one of the lethal human cancers worldwide and its incidence matches mortality, reflecting the poor prognosis of this disease. The surgical resection rate ...

Safety, Blood Levels and Effects of GW642444

GW642444 (the study medicine) is a new experimental medicine for treating asthma and chronic obstructive pulmonary disease (COPD). People with asthma and COPD suffer from breathlessness b...

Pilot Study of Vedic Medicine for Type 2 Diabetes

The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.

A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity

This study looks at a new study medicine for weight control in people with overweight or obesity. The aim of this study is to see if the study medicine is safe for people to take. The stud...

Companies [1056 Associated Companies listed on BioPortfolio]

Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd., established in 1970, is a leading biopharmaceutical company based in China with annual net sales of over $1.6 billion in 2016. Hengrui is devot...

China National Chemical Construction Jiangsu Company

China National Chemical Construction Jiangsu Company was established in January, 1992. It has independent corporate status and has the right to do foreign trade directly. It has one pesticide manufact...

Jiangsu Aolunda High-Tech. Industry Co., Ltd.

JIANGSU AOLUNDA HIGH-TECH., INDUSTRY CO.,LTD adjoinsthe Asian-Pacific banking centre of Shanghai, located in the Changjiang Delta of economic prosperity, it lies in the southeast of Jiangsu and border...

JIANGSU GUOTAI INTERNATIONAL GROUP

Jiangsu Guotai International Group is a complex group which covers international trade of textile, light industry, hardware, chemicals, minmetals, etc. Its department 3, specialized in hardware tradin...

SINOCHEM JIANGSU SUZHOU I/E CORP.

SINOCHEM JIANGSU SUZHOU I/E CORP. ESTABLISHED IN 1988, IS A SUBSIDIARY OF SINOCHEM AND A STATE-OWNED FOREIGH TRADE ENTERPRISE AUTHORISED BY THE CHINESE MINISTRY OF FOREIGH TRADE AND ECONOMIC C...

More Information about "Jiangsu Hengrui Medicine Co., Ltd." on BioPortfolio

We have published hundreds of Jiangsu Hengrui Medicine Co., Ltd. news stories on BioPortfolio along with dozens of Jiangsu Hengrui Medicine Co., Ltd. Clinical Trials and PubMed Articles about Jiangsu Hengrui Medicine Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Jiangsu Hengrui Medicine Co., Ltd. Companies in our database. You can also find out about relevant Jiangsu Hengrui Medicine Co., Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record